期刊
BIOORGANIC & MEDICINAL CHEMISTRY
卷 24, 期 16, 页码 3565-3570出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmc.2016.05.066
关键词
Anti-tumor; Bioreduction; Heterocyclic compound; NCI-DTP COMPARE program
资金
- Irish Research Council (IRC)
- College of Science, National University of Ireland Galway (NUI Galway)
- Cyprus Research Promotion Foundation [NEAYPODOMH/NEKYP/0308/02, YGEIA/BIOS/0308(BIE)/13]
- University of Cyprus
The thioredoxin (Trx)-thioredoxin reductase (TrxR) system plays a key role in maintaining the cellular redox balance with Trx being over-expressed in a number of cancers. Inhibition of TrxR is an important strategy for anti-cancer drug discovery. The natural product pleurotin is a well-known irreversible inhibitor of TrxR. The cytotoxicity data for benzo[1,2,4]wtriazin-7-ones showed very strong correlation (Pearson correlation coefficients similar to 0.8) to pleurotin using National Cancer Institute COMPARE analysis. A new 3-CF3 substituted benzo[1,2,4]triazin-7-one gave submicromolar inhibition of TrxR, although the parent compound 1,3-diphenylbenzo[1,2,4]triazin-7-one was more cytotoxic against cancer cell lines. Benzo[ 1,2,4]triazin-7-ones exhibited different types of reversible inhibition of TrxR, and cyclic voltammetry showed characteristic quasi-reversible redox processes. Cell viability studies indicated strong dependence of cytotoxicity on substitution at the 6-position of the 1,3-diphenylbenzo[1,2,4]triazin-7-one ring. (C) 2016 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据